Nia Evans, pharmacist and head of quality and regulations at AAH, talks about the impact that FMD is having on the industry and how AAH is supporting customers to remain compliant.
The Falsified Medicines Directive is one of the biggest changes to pharmacy I’ve seen in my career. Although the new legislation came into effect earlier this year, our whole industry still seems to be getting used to it and trying to figure out what they need to do to remain compliant.
In a busy pharmacy environment, it can be difficult to really get to grips with new systems and processes like this. I remember earlier in my career, as a pharmacist, trying to juggle the wants and needs of patients with all of the various rules and regulations that I needed to adhere to. Having run a pharmacy for 15 years, I have been in the same shoes as some of our AAH customers, so I completely understand their challenges. As a pharmacist you are wholly focussed on patient safety, but there seems to never be enough time in the day to do everything you want to do.
That’s why we decided to host this webinar. We get questions from our customers all the time about FMD and it struck me that we could do even more to help them. We wanted to invite our customers to bring their questions, and any frustrations, so that we can help them out. We took the approach that rather than telling them everything we know – and bombarding them with endless documents and guides – we would talk about the things that they specifically wanted to know.
Questions included: ‘What should I do in the event of an error message appearing?’ And ‘how long do I have to recommission stock if it is not collected by the patient?’
The feedback we’ve had from the attendees so far has been very positive. By taking this approach we were not only able to reinforce the knowledge that many people already had, we got to address their main concerns. This meant that we could be more efficient and give customers some valuable time back.